This week, there are 6 drugs in the patent and exclusivity list. They are: - NOVO NORDISK INC's OZEMPIC, containing active ingredient SEMAGLUTIDE - NOVO NORDISK INC's VICTOZA, containing active ingredient LIRAGLUTIDE - NOVO NORDISK INC's SAXENDA, containing active ingredient LIRAGLUTIDE - NIPPON SHINYAKU CO LTD's VILTEPSO, containing active ingredient VILTOLARSEN - VERTEX PHARMACEUTICALS INC's KALYDECO, containing active ingredient IVACAFTOR - EISAI INC's LENVIMA, containing active ingredient LENVATINIB MESYLATE

This week, there are 9 drugs in the patent and exclusivity list. They are: - BRISTOL MYERS SQUIBB CO's SPRYCEL, containing active ingredient DASATINIB - GILEAD SCIENCES INC's ZYDELIG, containing active ingredient IDELALISIB - SUMITOMO PHARMA SWITZERLAND GMBH's MYFEMBREE, containing active ingredient ESTRADIOL; NORETHINDRONE ACETATE; RELUGOLIX - BAYER HEALTHCARE PHARMACEUTICALS INC's NUBEQA, containing active ingredient DAROLUTAMIDE - BAYER HEALTHCARE PHARMACEUTICALS INC's LAMPIT, containing active ingredient NIFURTIMOX - VERTEX PHARMACEUTICALS INC's ORKAMBI, containing active ingredient IVACAFTOR; LUMACAFTOR - GENENTECH INC's EVRYSDI, containing active ingredient RISDIPLAM - ALNYLAM PHARMACEUTICALS INC's ONPATTRO, containing active ingredient PATISIRAN SODIUM - AMICUS THERAPEUTICS US LLC's GALAFOLD, containing active ingredient MIGALASTAT HYDROCHLORIDE

This week, there are 4 drugs in the patent and exclusivity list. They are: - GILEAD SCIENCES INC's LIVDELZI, containing active ingredient SELADELPAR LYSINE - ABBVIE INC's KYBELLA, containing active ingredient DEOXYCHOLIC ACID - GENENTECH INC's COTELLIC, containing active ingredient COBIMETINIB FUMARATE - ARCUTIS BIOTHERAPEUTICS INC's ZORYVE, containing active ingredient ROFLUMILAST

This week, there are 12 drugs in the patent and exclusivity list. They are: - NEURELIS INC's VALTOCO, containing active ingredient DIAZEPAM - DUCHESNAY INC's OSPHENA, containing active ingredient OSPEMIFENE - GILEAD SCIENCES INC's ZYDELIG, containing active ingredient IDELALISIB - SUN PHARMACEUTICAL INDUSTRIES LTD's WINLEVI, containing active ingredient CLASCOTERONE - SENTYNL THERAPEUTICS INC's ZOKINVY, containing active ingredient LONAFARNIB - GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LTD ENGLAND's TRELEGY ELLIPTA, containing active ingredient FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE - GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LTD ENGLAND's ANORO ELLIPTA, containing active ingredient UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE - GLAXO GROUP LTD ENGLAND DBA GLAXOSMITHKLINE's INCRUSE ELLIPTA, containing active ingredient UMECLIDINIUM BROMIDE - GILEAD SCIENCES INC's VEKLURY, containing active ingredient REMDESIVIR

This week, there are 6 drugs in the patent and exclusivity list. They are: - NOVARTIS PHARMACEUTICALS CORP's ENTRESTO, containing active ingredient SACUBITRIL; VALSARTAN - BIOCODEX SA's DIACOMIT, containing active ingredient STIRIPENTOL - PF PRISM CV's XALKORI, containing active ingredient CRIZOTINIB - INCYTE CORP's OPZELURA, containing active ingredient RUXOLITINIB PHOSPHATE - SERVIER PHARMACEUTICALS LLC's TIBSOVO, containing active ingredient IVOSIDENIB - GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LTD ENGLAND's KRINTAFEL, containing active ingredient TAFENOQUINE SUCCINATE

This week, there are 13 drugs in the patent and exclusivity list. They are: - GILEAD SCIENCES INC's BIKTARVY, containing active ingredient BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE - GILEAD SCIENCES INC's ODEFSEY, containing active ingredient EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR ALAFENAMIDE FUMARATE - GILEAD SCIENCES INC's VEMLIDY, containing active ingredient TENOFOVIR ALAFENAMIDE FUMARATE - GILEAD SCIENCES INC's GENVOYA, containing active ingredient COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE - GILEAD SCIENCES INC's DESCOVY, containing active ingredient EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE - FRESENIUS KABI USA LLC's OMEGAVEN, containing active ingredient FISH OIL TRIGLYCERIDES - ANI PHARMACEUTICALS INC's VEREGEN, containing active ingredient SINECATECHINS - NOVARTIS PHARMACEUTICALS CORP's PROMACTA KIT, containing active ingredient ELTROMBOPAG OLAMINE

This week, there are 4 drugs in the patent and exclusivity list. They are: - ASTRAZENECA AB's FARXIGA, containing active ingredient DAPAGLIFLOZIN - EAGLE PHARMACEUTICALS INC's RYANODEX, containing active ingredient DANTROLENE SODIUM - ULTRAGENYX PHARMACEUTICAL INC's DOJOLVI, containing active ingredient TRIHEPTANOIN - VIIV HEALTHCARE CO's RUKOBIA, containing active ingredient FOSTEMSAVIR TROMETHAMINE

This week, there are 18 drugs in the patent and exclusivity list. They are: - SUNOVION PHARMACEUTICALS INC's LATUDA, containing active ingredient LURASIDONE HYDROCHLORIDE - VERTEX PHARMACEUTICALS INC's TRIKAFTA (COPACKAGED), containing active ingredient ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR - VERTEX PHARMACEUTICALS INC's KALYDECO, containing active ingredient IVACAFTOR - VERTEX PHARMACEUTICALS INC's SYMDEKO (COPACKAGED), containing active ingredient IVACAFTOR; IVACAFTOR, TEZACAFTOR - TAKEDA PHARMACEUTICALS USA INC's KAZANO, containing active ingredient ALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDE - VERTEX PHARMACEUTICALS INC's ALYFTREK, containing active ingredient DEUTIVACAFTOR; TEZACAFTOR; VANZACAFTOR CALCIUM

This week, there are 9 drugs in the patent and exclusivity list. They are: - BRISTOL MYERS SQUIBB CO's POMALYST, containing active ingredient POMALIDOMIDE - VIATRIS SPECIALTY LLC's TOBI PODHALER, containing active ingredient TOBRAMYCIN - RHYTHM PHARMACEUTICALS INC's IMCIVREE, containing active ingredient SETMELANOTIDE ACETATE - PF PRISM CV's BOSULIF, containing active ingredient BOSUTINIB MONOHYDRATE - JANSSEN PHARMACEUTICALS INC's XARELTO, containing active ingredient RIVAROXABAN - BPI LABS LLC's ABLYSINOL, containing active ingredient ALCOHOL - HORIZON THERAPEUTICS USA INC's PROCYSBI, containing active ingredient CYSTEAMINE BITARTRATE - NOVARTIS PHARMACEUTICALS CORP's TAFINLAR, containing active ingredient DABRAFENIB MESYLATE - NOVARTIS PHARMACEUTICALS CORP's MEKINIST, containing active ingredient TRAMETINIB DIMETHYL SULFOXIDE